SII vs. ZVRA

Last updated Jun 13, 2026

SII (Sprott Inc) and ZVRA (Zevra Therapeutics Inc.) are both stocks. SII operates in Asset Management (Financial Services), while ZVRA operates in Biotechnology (Healthcare). Over the past 5 years, SII returned 25.04%/yr vs -2.85%/yr for ZVRA. At a 0.18 correlation, their price movements are largely independent.

Performance

SII vs. ZVRA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sprott Inc (SII) and Zevra Therapeutics Inc. (ZVRA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, SII achieves a 22.00% return, which is significantly lower than ZVRA's 41.18% return.

SII

• 1D: 2.63%
• 1M: -16.47%
• YTD: 22.00%
• 6M: 27.36%
• 1Y: 90.24%
• 3Y*: 56.34%
• 5Y*: 25.04%
• 10Y*: —

ZVRA

• 1D: -2.47%
• 1M: 13.76%
• YTD: 41.18%
• 6M: 51.86%
• 1Y: 35.01%
• 3Y*: 29.54%
• 5Y*: -2.85%
• 10Y*: -16.40%

*Multi-year figures are annualized to reflect compound growth (CAGR)

SII vs. ZVRA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
SII Sprott Inc	22.00%	137.17%	27.39%	5.00%	-24.09%	59.43%	-19.45%
ZVRA Zevra Therapeutics Inc.	41.18%	7.43%	27.33%	42.70%	-47.30%	-22.23%	131.02%

Correlation

The correlation between SII and ZVRA is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.21
Correlation (3Y) Calculated over the trailing 3-year period	0.20
Correlation (5Y) Calculated over the trailing 5-year period	0.22
Correlation (All Time) Calculated using the full available price history since Jun 29, 2020	0.18

Fundamentals

Market Cap SII : $2.20B ZVRA : $761.92M
EPS SII : $3.53 ZVRA : $2.16
PE Ratio SII : 33.69 ZVRA : 5.85
PS Ratio SII : 7.55 ZVRA : 5.94
PB Ratio SII : 5.78 ZVRA : 3.70
Total Revenue (TTM) SII : $377.77M ZVRA : $122.29M
Gross Profit (TTM) SII : $278.09M ZVRA : $104.94M
EBITDA (TTM) SII : $120.39M ZVRA : $149.15M

Return for Risk

SII vs. ZVRA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SII

SII Risk / Return Rank: 85
SII Sharpe Ratio Rank: 89
SII Sortino Ratio Rank: 85
SII Omega Ratio Rank: 84
SII Calmar Ratio Rank: 83
SII Martin Ratio Rank: 84

ZVRA

ZVRA Risk / Return Rank: 60
ZVRA Sharpe Ratio Rank: 61
ZVRA Sortino Ratio Rank: 62
ZVRA Omega Ratio Rank: 61
ZVRA Calmar Ratio Rank: 60
ZVRA Martin Ratio Rank: 57

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SII vs. ZVRA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Sprott Inc (SII) and Zevra Therapeutics Inc. (ZVRA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	SII	ZVRA	Difference
Sharpe ratio: Return per unit of total volatility	1.94	0.56	+1.38
Sortino ratio: Return per unit of downside risk	2.55	1.27	+1.29
Omega ratio: Gain probability vs. loss probability	1.33	1.16	+0.17
Calmar ratio: Return relative to maximum drawdown	2.84	0.81	+2.03
Martin ratio: Return relative to average drawdown	7.83	1.41	+6.42

SII vs. ZVRA - Sharpe Ratio Comparison

The current SII Sharpe Ratio is 1.94, which is higher than the ZVRA Sharpe Ratio of 0.56. The chart below compares the historical Sharpe Ratios of SII and ZVRA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

SII vs. ZVRA - Drawdown Comparison

The maximum SII drawdown since its inception was -47.81%, smaller than the maximum ZVRA drawdown of -99.27%. Use the drawdown chart below to compare losses from any high point for SII and ZVRA.

Drawdown Indicators

	SII	ZVRA	Difference
Max Drawdown Largest peak-to-trough decline	-47.81%	-99.27%	+51.46%
Max Drawdown (1Y) Largest decline over 1 year	-32.00%	-43.47%	+11.47%
Max Drawdown (3Y) Largest decline over 3 years	-32.00%	-43.47%	+11.47%
Max Drawdown (5Y) Largest decline over 5 years	-47.81%	-74.01%	+26.20%
Max Drawdown (10Y) Largest decline over 10 years	—	-97.85%	—
Current Drawdown Current decline from peak	-28.38%	-96.65%	+68.27%
Average Drawdown Average peak-to-trough decline	-21.08%	-86.41%	+65.33%
Ulcer Index Depth and duration of drawdowns from previous peaks	11.57%	24.87%	-13.30%

Volatility

SII vs. ZVRA - Volatility Comparison

The current volatility for Sprott Inc (SII) is 12.83%, while Zevra Therapeutics Inc. (ZVRA) has a volatility of 24.56%. This indicates that SII experiences smaller price fluctuations and is considered to be less risky than ZVRA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	SII	ZVRA	Difference
Volatility (1M) Calculated over the trailing 1-month period	12.83%	24.56%	-11.73%
Volatility (6M) Calculated over the trailing 6-month period	40.12%	40.23%	-0.11%
Volatility (1Y) Calculated over the trailing 1-year period	46.77%	62.90%	-16.13%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	37.64%	60.49%	-22.85%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	37.67%	81.46%	-43.79%

Dividends

SII vs. ZVRA - Dividend Comparison

SII's dividend yield for the trailing twelve months is around 1.26%, while ZVRA has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020
SII Sprott Inc	1.26%	1.33%	2.49%	2.95%	3.00%	2.22%	1.66%
ZVRA Zevra Therapeutics Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both SII and ZVRA in my portfolio?

SII and ZVRA have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, SII or ZVRA?

ZVRA has higher volatility (24.56%) compared to SII (12.83%). In terms of maximum drawdown, SII dropped -47.81% vs ZVRA's -99.27%.

Which has better risk-adjusted returns?

SII currently has the higher Sharpe Ratio (1.94 vs 0.56), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.